M&A Deal Summary |
|
|---|---|
| Date | 2025-10-31 |
| Target | Ypsotec |
| Sector | Manufacturing |
| Buyer(s) | Callista Private Equity |
| Sellers(s) | Ypsomed |
| Deal Type | Divestiture |
SEARCH BY
Callista Private Equity GmbH is a private equity firm focused on turnaround situations and carveouts. Callista targets opportunities with €10 to €200 million of revenue and does not have any sector preferences. The Firm's process is to is to acquire a controlling or a significant minority stake of loss-making entities and begin the process of repositioning. Callista Private Equity GmbH is headquartered in Munich, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 23 |
| Sector: Manufacturing M&A | 6 of 6 |
| Type: Divestiture M&A Deals | 20 of 20 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-10-11 |
AIOS
Überherrn, Germany AIOS supplies the automotive industry with high-quality headliners. As a one-stop shop for its customers, the entire value chain is offered internally, from research & development to innovative product development and series production. AIOS is based in Überherrn, Germany. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Medical Products |
| Employees | 2,644 |
| Revenue | 748M CHF (2025) |
Ypsomed develops and manufactures injection and infusion systems for self-administration of liquid medications, serving pharmaceutical and biotech firms as well as patients with chronic conditions.. Ypsomed was founded in 2003 and is based in Burgdorf, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Manufacturing M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: Switzerland M&A | 2 of 2 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-27 |
Ypsomed - Pen Needle & BGM Businesses
Burgdorf, Switzerland Ypsomed's Pen Needle & BGM Businesses provides pen needle and blood glucose monitoring products. |
Sell | - |
